HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Lucinda Tam Selected Research
Lucinda Tam Research Topics
Disease
4
Neoplasms (Cancer)
11/2022 - 01/2017
3
Fibrosis (Cirrhosis)
01/2023 - 01/2022
3
Inflammation (Inflammations)
10/2022 - 04/2017
2
Pain (Aches)
01/2023 - 01/2021
2
Asthma (Bronchial Asthma)
10/2022 - 01/2021
1
Congenital Pain Insensitivity
01/2023
1
Idiopathic Pulmonary Fibrosis
01/2023
1
Inborn Genetic Diseases (Disease, Hereditary)
01/2023
1
Breast Neoplasms (Breast Cancer)
09/2022
1
Hypersensitivity (Allergy)
09/2022
1
Liver Cirrhosis (Hepatic Cirrhosis)
01/2022
1
Cough
01/2021
1
Edema (Dropsy)
01/2021
1
Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2020
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2017
1
Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
03/2013
Drug/Important Bio-Agent (IBA)
2
Toll-Like Receptors (Toll-Like Receptor)
IBA
01/2020 - 04/2017
1
RNA (Ribonucleic Acid)
IBA
01/2023
1
Voltage-Gated Sodium Channels
IBA
01/2023
1
Collagen
IBA
01/2023
1
Enkephalins
IBA
01/2023
1
Leucine (L-Leucine)
FDA Link
11/2022
1
Peptide Hydrolases (Proteases)
FDA Link
10/2022
1
Cytokines
IBA
10/2022
1
Periostin
IBA
10/2022
1
Neutralizing Antibodies
IBA
10/2022
1
Kallikreins (Kallikrein)
IBA
10/2022
1
Biomarkers (Surrogate Marker)
IBA
10/2022
1
Estrogen Receptor alpha
IBA
09/2022
1
Estrogen Receptors
IBA
09/2022
1
Progesterone
FDA Link
Generic
09/2022
1
giredestrant
IBA
09/2022
1
Bleomycin (Blenoxane)
FDA Link
Generic
01/2022
1
myocardin
IBA
01/2022
1
Integrins
IBA
01/2022
1
Proteins (Proteins, Gene)
FDA Link
01/2022
1
Transcription Factors (Transcription Factor)
IBA
01/2022
1
GDC-0334
IBA
01/2021
1
Transient Receptor Potential Channels
IBA
01/2021
1
Antigen Receptors (Antigen Receptor)
IBA
01/2020
1
IgG Receptors (Fc gamma RI)
IBA
01/2020
1
Interleukin-1 Receptors (Interleukin 1 Receptor)
IBA
04/2017
1
Phosphotransferases (Kinase)
IBA
04/2017
1
Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)
IBA
04/2017
1
Mitogen-Activated Protein Kinases
IBA
04/2017
1
Mitogen-Activated Protein Kinase 3
IBA
04/2017
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
04/2017
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
01/2017
1
Bispecific Antibodies
IBA
01/2017
1
blinatumomab
IBA
01/2017
1
Immunoglobulin G (IgG)
IBA
03/2013
1
Cytidine Deaminase
IBA
03/2013
1
Antigens
IBA
03/2013
1
Myelin-Oligodendrocyte Glycoprotein
IBA
03/2013
Therapy/Procedure
3
Therapeutics
01/2023 - 01/2021
1
Analgesia
01/2023
1
Lasers (Laser)
01/2023